Voluntary HIV Screening in the General Population in France
ConditionHuman Immunodeficiency Virus (HIV)
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversité de Reims Champagne-Ardenne
About this trial
Since 2020, an increase in positive screenings for sexually transmitted infections, including HIV, has been observed.
Voluntary early screening plays an important role in the national strategy for HIV care in France. There are currently several methods that allow patients to undergo voluntary screening.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
18 years of age or older
Male or female
Regardless of sexual orientation
Whether or not they have previously undergone voluntary HIV testing
Disqualifiers
Minors
Refusing to participate in the study
Trial population
Subjects aged 18 years or older, whether or not they have previously undergone voluntary HIV testing, residing in France, and agreeing to participate in the study.
Trial design
Design model
Case-only
Time perspective
Cross-sectional
Treatments tested in this trial
data collections
Other interventiondata collections
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
The method(s) used for undergoing voluntary HIV testing questionnaire
The method(s) used for undergoing voluntary HIV testing: medical prescription, Center for Free Information, Testing, and Diagnosis, medical laboratory, rapid diagnostic test (RDT), or self-test
Time frame
Day 0Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov